Japan’s Taisho Pharmaceutical Holdings has released Japan’s first caffeine-free energy drink containing the botanical ingredient, enXtra, which has been clinically proven to improve alertness and focus up to five hours with or without caffeine.
Hong Kong’s Aptorum Group is launching a dietary supplement (NLS-2 dioscorea opposita bioactive nutraceutical tablets) to improve symptoms related to menopausal transitions, such as osteoporosis.
Chinese astaxanthin supplier Algae Health Science, a subsidiary of BGG World, has announced an expansion of its photobioreactor farming facility that will make it one of the biggest, if not the biggest, sources of the carotenoid in the world.
Optibiotix says sales of its flagship weight management product, Optibiome, soared by more than 2500% year-on-year, with Australia the latest market in its sights as part of its ambitious expansion plans.
The third annual NutraIngredients-Asia Awards returns this September, and entries are currently open for our coveted Ingredient of the Year categories.
China’s nicotinamide mononucleotide (NMN) supplier EffePharm is embarking on its first human clinical trial as it seeks to validate the anti-ageing effects and safety of its ingredient “Uthever”.
Robertet’s anti-stress ingredient, Extramel, has been approved as a food with function claim (FFC) by the Consumer Affairs Agency of Japan for use in health supplements.
Indian functional spice supplier Akay Natural Ingredients’ patented black cumin (nigella sativa) sleep aid ingredient will hit the US market in the upcoming months.
Japanese ingredient supplier Taiyo continues to expand the product forms of its prebiotic Sunfiber ingredient by pairing it with a probiotic as well as launching a new dual action women’s health product.
Sirio Pharma has obtained the ‘blue-hat’ approval for three of its probiotic formulations. The company now has ‘blue-hat’ certificates for four of its probiotic formulations in total.
Chinese e-commerce giant, JD has reported that sales of vitamin C dietary supplements on its platform were up five-fold, after the announcement of the novel coronavirus (COVID-19).
Chr. Hansen has sealed a deal to supply probiotic ingredients to Teijin Limited, a Japanese prebiotic firm, for use in functional and health food applications in its domestic market.
Kappa Bioscience is venturing into the vitamin K2 milk category in China, on top of its existing vitamin K2 nutraceutical business, after its synthetic-origin vitamin K2 MK-7 (menaquinone-7) was approved by China authorities for use in mother and children...
